Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 29, 2015 7:49 AM ET


Company Overview of Intra-Cellular Therapies, Inc.

Key Executives for Intra-Cellular Therapies, Inc.

NameBoard RelationshipsTitleAge
Sharon Mates Ph.D.19 RelationshipsCo-Founder, Chairman, Chief Executive Officer and President62
Allen A. Fienberg Ph.D.No RelationshipsCo-Founder and Vice President of Business Development55
Paul Greengard Ph.D.83 RelationshipsCo-Founder and Chairman of Scientific Advisory Board--
Lawrence J. Hineline CPANo RelationshipsChief Financial Officer, Vice President of Finance, Treasurer and Assistant Secretary59
Michael I. Halstead No RelationshipsSenior Vice President, General Counsel and Secretary42

Intra-Cellular Therapies, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sharon Mates Ph.D. 19 RelationshipsIntra-Cellular Therapies, Inc.62
Paul Greengard Ph.D. 83 RelationshipsIntra-Cellular Therapies, Inc.--
Joel S. Marcus J.D., CPA 259 RelationshipsAlexandria Real Estate Equities, Inc.68
Christopher D. Alafi Ph.D. 19 RelationshipsAlafi Capital Company LLC52
Carol A. Tamminga M.D. 44 RelationshipsACADIA Pharmaceuticals Inc.--
View All Board Members

Intra-Cellular Therapies, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee BSRobert L. Van Nostrand40 Relationships3 Executives
Compensation Committee J.D., CPAJoel S. Marcus259 Relationships3 Executives
Nominating Committee Ph.D.Christopher D. Alafi19 Relationships3 Executives
Corporate Governance Committee Ph.D.Christopher D. Alafi19 Relationships3 Executives
Advisory Board M.D.Carol A. Tamminga44 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$724.5K
Total Value of Options$954.0K
Compensation as of Fiscal Year 2014
Intra-Cellular Therapies, Inc. CEO Compensation
Industry Average


The Procter & Gamble Company Announces Executive Changes
July 28, 2015 9:53 AM ET
Aunt Fannies Appoints Barclay Hope as Board of Advisors
July 13, 2015 1:22 PM ET
Anpath Group, Inc. Elects Arthur R. Batson as Chief Executive Officer and President
July 09, 2015 8:43 PM ET
Katy Industries, Inc. Announces Executive and Management Changes
July 08, 2015 5:13 PM ET
Energizer Holdings, Inc. Announces Management Changes
July 07, 2015 12:31 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Intra-Cellular Therapies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at